Back

Prognostic implication of high residual platelet reactivity and antiplatelet therapy in patients undergoing percutaneous coronary intervention for chronic total occlusion

25 August 2018 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Coronary artery disease: revascularisation 1 Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Maria Grazia De Gregorio

Ospedale Santa Maria Nuova, Florence (Italy)

10 More presentations in this session

Presentation thumbnail
Professor R. Januszek (Krakow, PL)
Abstract
Presentation thumbnail
Doctor G. Quadri (Turin, IT)
Abstract Slides
Presentation thumbnail
Doctor H. Mehrad (Tabriz, IR)
Presentation thumbnail
Mr B. Oliveira Pedreira (Salvador, BR)
Abstract Slides
Presentation thumbnail
Doctor A. Basuoni (Muscat, OM)

Access the full session

Session thumbnail
Poster Session 1 - Coronary artery disease: revascularisation 1

The Event

Event poster

ESC Congress 2018

25 August 2018 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Long-term clinical outcomes of patients with chronic total coronary occlusion caused by intra-stent re-stenosis
27 August 2021
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023
thumbnail
Congress Presentation
Residual platelet activity and systemic inflammation in patients with chronic coronary syndrome in the context of aspirin monotherapy.
29 June 2021
thumbnail
Congress Presentation
The impact of smoking status on platelet reactivity and its association on clinical outcomes in east asian AMI patients with stent implantation
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources